Trial Details
UNKNOWNBasic Information
| Clinical ID | c565 |
|---|---|
| Identifier | NCT04114292 |
| Trial Title | TUDCA as a Therapy for Ulcerative Colitis (UC) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Tauroursoursodeoxycholic acid, brand name Tudcabil |
Participant Information
| Sponsor | Washington University School of Medicine |
|---|---|
| City | Creve Coeur |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2019-01-17 |
|---|---|
| Primary Completion Date | 2022-07-31 |
| Completion Date | 2022-07-31 |